Predict your next investment

HEALTHCARE | Medical Devices & Equipment

See what CB Insights has to offer



Date of IPO


About Kindly Group

Kindly Group (SHA: 603987) (HKG: 1501) is a holding company that, through its companies, manufactures medical devices in China.

Kindly Group Headquarter Location

658 Gaochao Rd Jiading District

Shanghai, Shanghai, 201803,


+86 021-59140058

Latest Kindly Group News

Unilever, 3M on list of firms eligible for China loans to ease coronavirus crisis -sources

Feb 19, 2020

February 19, 2020 SHANGHAI/BEIJING — Shanghai has compiled a list of firms, including local units of multi-nationals Unilever PLC and 3M Co, as eligible for millions of dollars in subsidized loans to ease any blow from the coronavirus outbreak, according to bankers and documents seen by Reuters. In an economically bruising three weeks, China has cordoned off cities and suspended transport links in an effort to slow the spread of the virus. Some lenders in the city have each received a list of firms compiled by the Shanghai branches of the Ministry of Industry and Information Technology (MIIT) and the National Development and Reform Commission (NDRC), according to seven bankers, each at a different lender. “Every bank in Shanghai is rushing to lend to the companies on its list, to earn political goodwill,” said one banker who had seen a list with 194 firms, including restaurant operators and property developers. Other lenders have received shorter versions of the list, bankers said. Companies have the option to nominate themselves to be added to the overall list. Each lender then determines independently whether to approach a company on its list and offer finance, according to the bankers. Companies producing medical supplies and which are “backbone enterprises” providing daily necessities are eligible for the special loans, according to a notice on the Shanghai MIIT’s website. China is trying to deal with a nationwide shortage of medical supplies, from face masks to protective suits, while hospitals in central Hubei province – the epicenter of the outbreak – struggle to manage hundreds of new cases a day. One bank’s list of firms reviewed by Reuters included 3M Medical Devices and Materials Manufacturing (Shanghai) Co Ltd, Unilever (China) Co Ltd as well as medical supply firms Shanghai Kindly Enterprise Development Group Co Ltd and Tellgen Corp. There is no indication from the list that loans offered will necessarily be sought, or that such firms are in any financial need. The Bank of Shanghai Co Ltd told Reuters it will lend 5.5 billion yuan ($786 million) to 57 firms on its list. So far, 430 million yuan of that has been drawn down at an average interest rate of 2.65%, the bank said. With subsidies, the borrower only pays 1.32%, it said. Under a similar program in Beijing, companies sought bank loans totalling at least $8.2 billion, Reuters reported earlier this month. The aim of the loans is to ensure financial support to key companies helping prevent and fight the epidemic, the Shanghai government notice said. Shanghai authorities are compiling the list to help the central bank, the People’s Bank of China (PBOC), funnel 300 billion yuan of cheap loans to virus-hit companies nationwide. Shanghai-based medical equipment manufacturer Derlar, on a list seen by Reuters, put its name down for financing last week, said a person surnamed Shen in Derlar’s finance department, adding the firm had not yet received any money. Shanghai Kaibao Pharmaceutical Co Ltd, on the same list, said it had not yet received a loan, in response to Reuters’ questions about its application. A person surnamed Ren in the firm’s finance department added it will provide more details if money is received. Banks which have received a list of potential borrowers include the Shanghai branches of Ping An Bank Co Ltd , China CITIC Bank Corp Ltd, China Guangfa Bank Co Ltd, China Merchants Bank Co Ltd , Shanghai Huarui Bank and the Bank of Ningbo Co Ltd , according to people working at those lenders, who declined to be named as they were not authorized to speak to the media. The lenders, MIIT, NDRC and PBOC did not respond to requests for comment from Reuters. A spokeswoman from Unilever said it had “no current plans to apply for any financing support.” 3M and other companies listed including Shanghai Kindly Enterprise Development Group and Tellgen did not respond to requests for comment. NO INTEREST One Shanghai-based face mask manufacturer on the list will not pay any interest on a loan from the Shanghai branch of the Bank of Ningbo if government subsidies are taken into account, said a person with direct knowledge of the matter. Shanghai Roche Pharmaceuticals Ltd, a unit of Swiss drug firm Roche Holding AG, was also on a loan list seen by Reuters. A spokesman for the firm said “the company did not apply for any loans.” After banks make the loans, they can then claim more funding from the central bank, according to the PBOC’s website. China has issued more than 1,600 force majeure certificates to shield companies from legal damages arising from the coronavirus outbreak, state news agency Xinhua reported on Tuesday, an indication of difficulties faced by Chinese firms. ($1=6.99 yuan) (Reporting by Engen Tham in Shanghai and Cheng Leng and Zhang Yan in Beijing; Additional reporting by Brenda Goh and Shanghai newsroom; Editing by Tony Munroe, Lincoln Feast and Christopher Cushing)

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Kindly Group

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Kindly Group is included in 1 Expert Collection, including Medical Devices.


Medical Devices

7,496 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.